v3.26.1
INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Joint Venture Related Financial Statement Activity - Earnings and Cash Flow (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
May 31, 2026
Feb. 22, 2026
Nov. 23, 2025
Aug. 24, 2025
May 25, 2025
Feb. 23, 2025
Nov. 24, 2024
Aug. 25, 2024
May 31, 2026
May 25, 2025
May 26, 2024
Schedule of Equity Method Investments [Line Items]                      
Total net sales $ 4,609.6 $ 4,436.7 $ 4,860.8 $ 4,517.5 $ 4,556.2 $ 4,842.2 $ 5,240.1 $ 4,848.1 $ 18,424.6 $ 19,486.6 $ 19,857.2
Net advances (repayments)                 31.8 (13.3) 2.7
Dividends received                 39.0 44.6 50.4
Corporate Joint Venture                      
Schedule of Equity Method Investments [Line Items]                      
Total net sales                 6.7 7.8 4.8
Net advances (repayments)                 31.8 (13.3) 2.7
Dividends received                 $ 39.0 $ 44.6 $ 50.4